header
Image from OpenLibrary

Determination of capecitabine and its metabolites in plasma of Egyptian colorectal cancer patients / Sara Mohamed Elsayed Shams Eldin ; Supervised Sahar Abdelmaksoud , Rasha Hanafi , Salem Eid

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Sara Mohamed Elsayed Shams Eldin , 2015Description: 71 Leaves : charts ; 30cmSubject(s): Dissertation note: Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceulical Chemistry Summary: Colorectal cancer (CRC) is a type of cancer that is constantly increasing in incidence worldwide in addition to the national level. It has variable signs and symptoms starting from change in bowel habit to nausea and vomiting. Chemotherapeutic agents are often preseribed in CRC disease such as capecitabine (CCB) and 5-fluorouracil (FU). CCB is the prodrag of FU in oral dosage form, which makes it preferable by physicians, since no hospitalization is needed for drug administration
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceulical Chemistry

Colorectal cancer (CRC) is a type of cancer that is constantly increasing in incidence worldwide in addition to the national level. It has variable signs and symptoms starting from change in bowel habit to nausea and vomiting. Chemotherapeutic agents are often preseribed in CRC disease such as capecitabine (CCB) and 5-fluorouracil (FU). CCB is the prodrag of FU in oral dosage form, which makes it preferable by physicians, since no hospitalization is needed for drug administration

There are no comments on this title.

to post a comment.